PT99051A - Processo para a preparacao de formoterol e de compostos com ele relacionados e seus derivados - Google Patents

Processo para a preparacao de formoterol e de compostos com ele relacionados e seus derivados

Info

Publication number
PT99051A
PT99051A PT99051A PT9905191A PT99051A PT 99051 A PT99051 A PT 99051A PT 99051 A PT99051 A PT 99051A PT 9905191 A PT9905191 A PT 9905191A PT 99051 A PT99051 A PT 99051A
Authority
PT
Portugal
Prior art keywords
formoterol
related compounds
derivatives
preparation
directed
Prior art date
Application number
PT99051A
Other languages
English (en)
Other versions
PT99051B (pt
Inventor
Edib Jakupovic
Jan William Trofast
Lena Katarina Mansson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of PT99051A publication Critical patent/PT99051A/pt
Publication of PT99051B publication Critical patent/PT99051B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Steroid Compounds (AREA)
PT99051A 1990-09-26 1991-09-25 Processo para a preparacao de formoterol e de compostos com ele relacionados e seus derivados PT99051B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003057A SE9003057D0 (sv) 1990-09-26 1990-09-26 New process

Publications (2)

Publication Number Publication Date
PT99051A true PT99051A (pt) 1992-08-31
PT99051B PT99051B (pt) 1999-02-26

Family

ID=20380456

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99051A PT99051B (pt) 1990-09-26 1991-09-25 Processo para a preparacao de formoterol e de compostos com ele relacionados e seus derivados

Country Status (28)

Country Link
EP (1) EP0550612B1 (pt)
JP (1) JP2801401B2 (pt)
KR (1) KR0179639B1 (pt)
AT (1) ATE134990T1 (pt)
AU (1) AU652386B2 (pt)
BG (1) BG61605B1 (pt)
CA (1) CA2091343C (pt)
CZ (1) CZ284256B6 (pt)
DE (1) DE69117768T2 (pt)
DK (1) DK0550612T3 (pt)
EE (1) EE02979B1 (pt)
ES (1) ES2084831T3 (pt)
FI (1) FI111714B (pt)
GR (1) GR3020134T3 (pt)
HK (1) HK52297A (pt)
HU (1) HU214054B (pt)
IE (1) IE74387B1 (pt)
IS (1) IS1684B (pt)
LT (1) LT3813B (pt)
LV (1) LV10770B (pt)
NO (1) NO301709B1 (pt)
PL (1) PL166434B1 (pt)
PT (1) PT99051B (pt)
RU (1) RU2079486C1 (pt)
SE (1) SE9003057D0 (pt)
SG (1) SG43150A1 (pt)
SK (1) SK22793A3 (pt)
WO (1) WO1992005147A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6866839B2 (en) 1991-04-05 2005-03-15 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US6299863B1 (en) 1992-04-03 2001-10-09 Sepracor Inc. Aerosol formulations containing micronized optically pure (R,R) formoterol for bronchodilating therapy
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5629200A (en) * 1993-11-18 1997-05-13 Daicel Chemical Industries, Ltd. Production of optically active 2-amino-1-phenylethanol derivatives by asymetrical assimilation
SE9404080L (sv) * 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
PT938467E (pt) * 1996-11-11 2002-11-29 Sepracor Inc Processo para a preparacao de isomeros opticamente puros de formoterol
US6040344A (en) 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
US6303145B2 (en) 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
DE10290563D2 (de) * 2001-02-22 2004-04-29 Universitaetsklinikum Charite Mittel zur Hemmung von Tumorzellen
US6472563B1 (en) 2001-11-09 2002-10-29 Sepracor Inc. Formoterol tartrate process and polymorph
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
TW200738634A (en) 2005-08-02 2007-10-16 Astrazeneca Ab New salt
WO2008035380A2 (en) * 2006-09-19 2008-03-27 Natco Pharma Limited An improved process for the preparation of high purity formoterol and its pharmaceutically acceptable salts
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
US20100288022A1 (en) * 2007-10-29 2010-11-18 Mylan India Private Limited Novel chromatography methods
AU2008356409B2 (en) 2008-05-13 2012-01-19 Astrazeneca Ab Quinuclidine derivatives as muscarinic M3 receptor antagonists
CN101921200B (zh) * 2009-06-16 2014-01-15 上海医药工业研究院 一种n-苄基-1-(4-甲氧基苯基)-2-丙胺的制备方法
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
CN115368250A (zh) * 2022-09-02 2022-11-22 博诺康源(北京)药业科技有限公司 拆分福莫特罗手性中间体的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2366625C2 (pt) * 1972-02-05 1988-06-09 Yamanouchi Pharmaceutical Co., Ltd., Tokio/Tokyo, Jp
GB1468156A (en) * 1973-07-19 1977-03-23 Ici Ltd Phenylethylamine derivatives
JPS643121A (en) 1987-06-25 1989-01-06 Mitsubishi Kasei Corp Remedy for endometriosis
ES2005492A6 (es) 1987-12-23 1989-03-01 Lasa Lab Procedimiento de obtencion de n-(2-hidroxi-5-(1-hidroxi-2((2- (4-metoxifenil)-1metiletil)amino)etil)fenil)foramida (i).

Also Published As

Publication number Publication date
SG43150A1 (en) 1997-10-17
JP2801401B2 (ja) 1998-09-21
NO301709B1 (no) 1997-12-01
CZ44293A3 (en) 1994-01-19
HU214054B (en) 1997-12-29
NO931058D0 (no) 1993-03-23
ATE134990T1 (de) 1996-03-15
DE69117768T2 (de) 1996-08-29
AU652386B2 (en) 1994-08-25
LTIP1715A (en) 1995-07-25
ES2084831T3 (es) 1996-05-16
BG97576A (bg) 1994-03-31
FI931333A (fi) 1993-04-22
EP0550612B1 (en) 1996-03-06
CZ284256B6 (cs) 1998-10-14
IE913373A1 (en) 1992-04-08
PL166434B1 (pl) 1995-05-31
WO1992005147A1 (en) 1992-04-02
LT3813B (en) 1996-03-25
PT99051B (pt) 1999-02-26
IS1684B (is) 1998-02-24
IE74387B1 (en) 1997-07-30
RU2079486C1 (ru) 1997-05-20
BG61605B1 (bg) 1998-01-30
NO931058L (no) 1993-03-23
IS3756A7 (is) 1992-03-27
LV10770A (lv) 1995-08-20
FI111714B (fi) 2003-09-15
SE9003057D0 (sv) 1990-09-26
SK22793A3 (en) 1993-07-07
FI931333A0 (fi) 1993-03-25
LV10770B (en) 1996-04-20
CA2091343A1 (en) 1992-03-27
HU9300867D0 (en) 1993-06-28
EE02979B1 (et) 1997-04-15
DK0550612T3 (da) 1996-07-22
CA2091343C (en) 2002-07-09
JPH06501262A (ja) 1994-02-10
AU8652091A (en) 1992-04-15
DE69117768D1 (de) 1996-04-11
GR3020134T3 (en) 1996-08-31
HK52297A (en) 1997-05-02
EP0550612A1 (en) 1993-07-14
HUT65912A (en) 1994-07-28
KR0179639B1 (ko) 1999-05-15

Similar Documents

Publication Publication Date Title
PT99051A (pt) Processo para a preparacao de formoterol e de compostos com ele relacionados e seus derivados
FI104170B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-amidopyratsolijohdannaisten valmistamiseksi
NO914667D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater
PT97866A (pt) Processo para a preparacao de uma composicao de um fluxo vitreo
FI905941A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi
FI881103A0 (fi) Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi
PT96871A (pt) Processo para a preparacao de compostos 3-arilcarbonil-1h-indol uteis como agentes terapeuticos
RU93005269A (ru) Способ получения формотерола и родственных соединений
FI930723A0 (fi) Menetelmä terapeuttisesti aktiivisten tiatsolidiinijohdannaisten valmistamiseksi
FI98455B (fi) Menetelmä terapeuttisesti aktiivisten indolijohdannaisten valmistamiseksi
ES545330A0 (es) Un procedimiento para preparar derivados de 1,3-difosfonato
ES2071303T3 (es) Compuestos homologados de vitamina d2 y los derivados hidroxilados en 1alfa correspondientes.
IT9019914A0 (it) Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria
PT99249A (pt) Processo para a preparacao de derivados de piperazina
FI925518A (fi) Menetelmä terapeuttisesti aktiivisten 1-piperidinyylialkanoyyliaryylisulfonamidijohdannaisten valmistamiseksi
PT90262A (pt) Processo para a preparacao de novos derivados trienicos com estrutura cromenica
ES2089176T3 (es) Procedimiento para la preparacion de carboditioatos de piperidina fluorometil-sustituidos.
PT98186A (pt) Processo para a preparacao de purinil- e de pirimidinil-tetra-hidrofuranos e de composicoes farmaceuticas que os contem
ES2032573T3 (es) Procedimiento de preparacion de derivados de 4,4-dimetil-tetrahidropir-2-ona.
FI841207A (fi) Troponderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutisk komposition.
FI894813A (fi) Menetelmä terapeuttisesti aktiivisten 2-metoksikarbonyylisubstituoitujen N,N'-di(trimetoksibentsoyyli)piperatsiinijohdannaisten valmistamiseksi
SE9000288D0 (sv) New use
IT1243368B (it) Uso del bendazac e dei suoi sali farmaceuticamente accettabili

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920504

FG3A Patent granted, date of granting

Effective date: 19981112

PD3A Change of proprietorship

Owner name: ASTRA AKTIEBOLAG

Effective date: 19990209

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20131112